FFL
IBB icon

Financial Freedom LLC’s iShares Biotechnology ETF IBB Stock Holding History

Financial Freedom LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Hold
101
– – 0.01% 253
2025
Q4 		$17K Hold
101
– – 0.01% 237
2025
Q3 		$14.5K Hold
101
– – 0.01% 252
2025
Q2 		$12.7K Hold
101
– – 0.01% 255
2025
Q1 		$12.9K Sell
101
-74
-42% -$10K 0.01% 259
2024
Q4 		$23.2K Hold
175
– – 0.01% 207
2024
Q3 		$25.5K Hold
175
– – 0.01% 199
2024
Q2 		$24.1K Hold
175
– – 0.01% 206
2024
Q1 		$24.1K Hold
175
– – 0.01% 208
2023
Q4 		$23.8K Hold
175
– – 0.02% 205
2023
Q3 		$21.4K Buy
175
+100
+133% +$12.7K 0.02% 208
2023
Q2 		$9.52K Hold
75
– – 0.01% 282
2023
Q1 		$9.69K Hold
75
– – 0.01% 273
2022
Q4 		$9.85K Buy
+75
New +$9.69K 0.01% 269

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Freedom LLC's IBB Position: Q1 2026 in Review

Financial Freedom LLC held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 101 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #253.

Financial Freedom LLC first reported a position in IBB in Q4 2022 and has held it in 14 quarters since. The position peaked at $25.5K in Q3 2024. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Financial Freedom LLC held 101 shares of iShares Biotechnology ETF worth $17K as of Q1 2026.
  • Financial Freedom LLC left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #253 holding.
  • Financial Freedom LLC first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 14 quarters since.
  • Financial Freedom LLC's iShares Biotechnology ETF position peaked at $25.5K in Q3 2024.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.